fluspirilene has been researched along with Atheroma in 2 studies
Fluspirilene: A long-acting injectable antipsychotic agent used for chronic schizophrenia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, H | 1 |
| Narula, J | 1 |
| Virmani, R | 1 |
| Ying, YL | 1 |
| Chen, YC | 1 |
| Jandeleit-Dahm, K | 1 |
| Peter, K | 1 |
2 other studies available for fluspirilene and Atheroma
| Article | Year |
|---|---|
Juxta-Lesional Cavitary Formation in Coronary Intervention: Imaginary, Incidental, or Iatrogenic?
Topics: Fluspirilene; Humans; Iatrogenic Disease; Plaque, Atherosclerotic; Tomography, Optical Coherence; Ul | 2018 |
GLP-1 receptor agonists: An example of the challenge for animal models to predict plaque instability/rupture and cardiovascular outcomes.
Topics: Animals; Cardiovascular System; Fluspirilene; Glucagon-Like Peptide-1 Receptor; Models, Animal; Plaq | 2017 |